飞凯材料 reported revenue of ¥1.72B for the period ended 2026-06-30, +17.8% year on year. Net income was ¥0.28B, a 16.3% net margin on a 40.7% gross margin. The largest revenue line is 显示材料 at 48% of the total. Free cash flow for the period was ¥0.21B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.72B | +17.8% |
| Gross profit | ¥0.70B | — |
| Operating income | ¥0.32B | — |
| Net income | ¥0.28B | +24.9% |
| Gross margin | 40.7% | Net margin 16.3% |
| Revenue Q/Q | -2.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 显示材料 | ¥0.82B | 47.9% |
| 紫外固化材料 | ¥0.40B | 23.2% |
| 半导体材料 | ¥0.36B | 20.8% |
| 有机合成材料 | ¥0.12B | 7.1% |
| 其他 | ¥0.02B | 1.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.02B | 59.3% |
| R&D | ¥0.10B | 6.0% |
| SG&A | ¥0.24B | 14.2% |
| Tax & other | ¥0.04B | 2.1% |
| Item | Amount |
|---|---|
| Total assets | ¥7.17B |
| Total liabilities | ¥1.79B |
| Shareholders' equity | ¥5.38B |
| Equity / assets | 75.1% |
| Operating cash flow | ¥0.25B |
| Capital expenditure | ¥0.04B |
| Free cash flow | ¥0.21B |
| Cash conversion (OCF / net income) | 170% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气 ・ 道氏技术 ・ 正业科技 ・ 金盾股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies